ANGPT2 and bronchopulmonary dysplasia: The pro-apoptotic activity of Ang2 is also known to be reduced in the presence of increased levels of VEGF [52] which may explain in part why treatment with a miR-451 was associated with both increased expression of Ang2 and mitigation of the BPD phenotype.